OC-0264: Fast biological RBE modeling for carbon ion therapy using the repair-misrepair-fixation (RMF) model  by Kamp, F. et al.
S122                                                                                     ESTRO 35 2016 
 _____________________________________________________________________________________________________ 
4German Cancer Research Center DKFZ Heidelberg and 
German Cancer Consortium DKTK partner site Dresden, 
Dresden, Germany 
5Helmholtz-Zentrum Dresden – Rossendorf, Institute of 
Radiooncology, Dresden, Germany 
 
Purpose or Objective: Radiomics is a new emerging field in 
which machine-learning algorithms are applied to analyse and 
mine imaging features with the goal to individualize radiation 
therapy. The identification of an effective and robust 
machine-learning method through systematic evaluations is 
an important step towards stable and clinically relevant 
radiomic biomarkers. Thus far, only few studies have 
addressed this question. Therefore, we investigated different 
machine-learning approaches to develop a radiomic signature 
and compared those signatures regarding to their predictive 
power. 
 
Material and Methods: Two datasets of patients with UICC 
stage III/IV advanced head and neck squamous cell carcinoma 
(HNSCC) were used for training and validation (N=23 and 
N=20, respectively, NCT00180180, Zips et al. R&O 105: 21–28, 
2012). All patients underwent FMISO- and FDG-PET/CT scans 
at several time points. We defined 45 radiomic-based image 
features, which were extracted from the gross tumour 
volume, delineated in CT0/FDG-PET0 and FMISO-PET0 
(baseline; 0 Gy), FMISO-PET20 (end of week 2; 20 Gy) and 
CT40 (end of week 4; 40 Gy). Furthermore, we computed the 
delta features CT40/CT0 as well as FMISO-PET20/FMISO-
PET0, leading to 315 image features in total. Radiomic 
signatures were built for the endpoints local tumour control 
(LC) and overall survival (OS) based on a semi-automatic 
approach using Cox regression models (SA) and automatic 
methods using random forests (RF) as well as boosted Cox 
regression models (CB). All models are applied to continuous 
survival endpoint data and were trained on the training 
cohort using a repeated (50 times) 2-fold cross validation. 
The prognostic performance was evaluated on the validation 
cohort using the concordance index (CI). 
 
Results: The SA signature achieved the best prognostic 
performance for local tumour control (CI=0.93). Furthermore, 
the CB and RF signatures performed well in the validation 
cohort (CI=0.86 and CI=0.74, respectively). The signature for 
overall survival built by the RF model achieved the best 
performance (CI=0.91, compared to CI=0.87 by the CB model 
and CI=0.77 by the SA method). Figure 1 exemplarily shows 
Kaplan-Maier curves determined by the SA radiomic signature 
for both endpoints. The patients could be statistically 
significantly separated into a low and high risk survival group 
in the training (LC: p=0.015 and OS: p=0.023) and the 
validation cohorts (LC: p=0.003 and OS: p=0.001). 
 
 
Conclusion: Our evaluation reveals that the RF and the CB 
model yield the highest predictive performance for both 
endpoints. The obtained signatures and features will be 
tested for stability using further delineation datasets. The 
comparison of machine-learning methods within the 
Radiomics processing chain is one important step to increase 
the robustness of the results and standardization of methods. 
 
Proffered Papers: Physics 7: Treatment planning: 
optimisation algorithms  
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Purpose or Objective: To compare fully non-coplanar liver 
SBRT with: 1) VMAT and 2) VMAT plus a few computer-
optimized non-coplanar beams. Main endpoint was the 
highest feasible biologically effective dose (BED) to the 
tumor within hard OAR constraints. 
 
Material and Methods: In our institution, liver metastases are 
preferentially treated with 3 fractions of 20 Gy. If not 
feasible for OAR constraints, the total dose of 60Gy is 
delivered in either 5 or 8 fractions. Assuming a tumor a/b of 
10 Gy, the tumor BEDs for 3x20 Gy, 5x12 Gy, and 8x7.5 Gy 
are 180 Gy, 132 Gy, and 105 Gy, respectively. For fifteen 
patients with liver metastases we generated (i) plans with 15-
25 computer-optimized non-coplanar IMRT beams (fully NC), 
(ii) VMAT plans, and (iii) plans combining VMAT with a few 
optimized non-coplanar IMRT beams (VMAT+NC). All plans 
were generated using our platform for fully automated multi-
criterial treatment planning including beam angle 
optimization, based on the in-house iCycle optimizer and 
Monaco (Elekta AB, Stockholm, Sweden). For each patient 
and treatment technique we established the lowest number 
of feasible treatment fractions, i.e. 3, 5 or 8 to achieve 
highest possible tumor BED. All generated plans were 
clinically deliverable at our linear accelerators (Elekta AB, 
Stockholm, Sweden). 
 
Results: Using 15-25 computer-optimized non-coplanar IMRT 
beams, 12 of the 15 patients (80%) could be treated with 3 
fractions, one patient (7%) with 5 fractions, and two patients 
(13%) with 8 fractions. With VMAT only, achievable tumor 
BEDs were considerably lower for 1/3 of the patients, for 5 
patients the fraction number needed to be increased to 
protect OARs: for 4 patients from 3 to 5 and for 1 from 5 to 8 
(Table). Otherwise the healthy liver constraint (1 patient), or 
the constraint for the stomach (2 patients), bowel (1 patient) 
or oesophagus (1 patient) would be exceeded. With 
VMAT+NC, for all 5 patients this could be fully restored, 
resulting in the same low fraction numbers as for fully NC 
(Table). Contributions of the added NC IMRT beams to the 
PTV mean dose were relatively high: one patient needed a 
single IMRT beam with a weight of 14.8%, 1 patient needed 2 
IMRT beams with a total weight of 39.9%, 2 patients required 
3 IMRT beams with total weights of 45.5% and 47.7%, and 1 
patient had 4 IMRT beams with a total weight of 46.1%. 
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Conclusion: A novel approach for liver SBRT at a linear 
accelerator was developed. The basis of the treatment is a 
fast VMAT plan, supplemented with a few (1-4) computer-
optimized non-coplanar IMRT beams. In terms of achievable 
tumor BED within the clinical OAR constraints, this approach 
is equivalent to time-consuming, fully non-coplanar 
treatment. The technique is currently also explored for other 
treatment sites. 
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Purpose or Objective: The physical and biological 
advantages of carbon ion beams over conventional x-rays 
have not been fully exploited in particle therapy and may 
result in higher levels of local tumor control and 
improvements in normal tissue sparing. Treatment planning 
must account for physical properties of the beam as well as 
differences in the relative biological effectiveness (RBE) of 
ions compared to photons. In this work, we present a fast 
RBE calculation approach, based on the decoupling of 
physical properties and the (α/β)x. The (α/β)x ratio is 
commonly used to describe the radiosensitivity of irradiated 
cells or organs. The decoupling is accomplished within the 
framework of the repair-misrepair-fixation (RMF) model. 
 
Material and Methods: Carbon ion treatment planning was 
implemented by optimizing the RBE-weighted dose (RWD) 
distribution. Biological modeling was performed with the RMF 
and Monte Carlo Damage Simulation (MCDS) models. The RBE 
predictions are implemented efficiently by a decoupling 
approach which allows fast arbitrary changes in (α/β)x by 
introducing two decoupling variables c1 and c2. Dose-
weighted radiosensitivity parameters of the ion field are 
calculated as (Fig 1). This decoupling can be used during and 
after the optimization.  
 Carbon ion treatment plans were optimized for several 
patient cases. Predicted trends in RBE are compared to 
published cell survival data. A comparison of the RMF model 
predictions with the clinically used Local Effect Model (LEM1 
and 4) is performed on patient cases. 
 
 
 
Figure 1: Axial CT slice of a treatment plan using the RMF 
model. The astrocytoma plan with two carbon ion fields was 
optimized on 3 Gy(RBE) using a spatially constant (α/β)x = 2 
Gy (αx = 0.1 Gy^-1, βx = 0.05 Gy^-2). The PTV is shown in 
red, along with 3 organs at risk: left optic nerve (green), left 
eye (orange) and left lens (brown). The panels show A) RWD, 
B) RBE, C) physical dose d and the beam geometry in D. The 
two decoupling variables c1 and c2 are shown in panels E and 
F, along with αD and βD in panels G and H. 
 
Results: The presented implementation of the RMF model is 
very fast, allowing online changes of the (α/β)x including a 
voxel-wise recalculation of the RBE. For example, a change 
of the (α/β)x including a complete biological modeling and a 
recalculation of RBE and RWD for 290000 voxels took 4 ms on 
a 4 CPU, 3.2 GHz workstation. Changing the (α/β)x of a single 
structure, e.g. a planning target volume (PTV) of 270 cm^3 
(35000 voxels), takes 1 ms in the same computational 
environment. The RMF model showed reasonable agreement 
with published data and similar trends as the LEM4. 
 
Conclusion: The RMF model is suitable for radiobiological 
modeling in carbon ion therapy and was successfully 
validated against published cell data. The derived decoupling 
within the RMF model allows extremely fast changes in 
(α/β)x, facilitating online adaption by the user. This provides 
new options for radiation oncologists, facilitating online 
variations of the RBE during treatment plan evaluation. 
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Purpose or Objective: In treatment planning for proton 
therapy, robust optimizers typically limit their scope to 
systematic setup and proton range errors. Treatment 
execution errors (patient and organ motion or breathing) are 
seldom included. In analytical dose calculation methods as 
pencil beam algorithms, the only way to simulate motion 
errors is to sample random shifts from a probability 
distribution, which increases the computation time for each 
simulated shift. However, the stochastic nature of Monte 
Carlo methods allows random errors to be simulated in a 
single dose calculation. 
 
Material and Methods: An in-house treatment planning 
system, based on worst-case scenario optimization, was used 
to create the plans. The optimizer is coupled with a super-
fast Monte Carlo (MC) dose calculation engine that enables 
computing beamlets for optimization, as well as final dose 
distributions (less than one minute for final dose). Two 
strategies are presented to account for random errors: 1) Full 
robust optimization with beamlets that already include the 
effect of random errors and 2) Mixed robust optimization, 
where the nominal beamlets are involved but a correction 
term C modifies the prescription. Starting from C=0, the 
method alternates optimization of the spot weights with the 
nominal beamlets and updates of C, with C = Drandom – 
Dnominal and where Drandom results from a regular MC 
computation (without pre-computed beamlets) that simulates 
random errors. Updates of C can be triggered as often as 
necessary by running the MC engine with the last corrected 
values for the spot weights as input. MC simulates random 
errors by shifting randomly the starting point of each 
particle, according to the distribution of random errors. Such 
strategy assumes a sufficient number of treatment fractions. 
The method was applied to lung and prostate cases. For both 
patients the range error was set to 3%, systematic setup error 
to 5mm and standard deviation for random errors to 5 mm. 
Comparison between full robust optimization and the mixed 
strategy (with 3 updates of C) is presented. 
 
Results: Target coverage was far below the clinical 
constraints (D95 > 95% of the prescribed dose) for plans 
where random errors were not simulated, especially for lung 
case. However, by using full robust or mixed optimization 
strategies, the plans achieved good target coverage (above 
